{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-022896","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.505450+00:00","generated_at":"2026-06-02T02:39:48.133773+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ginkgo Bioworks receives NYSE delisting notice for stock price below $1 for 30 trading days","bullets":["NYSE notified Ginkgo on May 7, 2024 that average closing price of Class A common stock was below $1.00 over 30 consecutive trading days.","No immediate delisting; six-month cure period to regain compliance by closing at $1.00 or above on last trading day of any calendar month.","Stock continues trading on NYSE under symbol 'DNA' with '.BC' designation indicating non-compliance.","Company intends to regain compliance and is evaluating all available options; business operations unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-022896","json":"https://secwatch.observer/filing/0001628280-24-022896.json","markdown":"https://secwatch.observer/filing/0001628280-24-022896.md","text":"https://secwatch.observer/filing/0001628280-24-022896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/0001628280-24-022896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/dna-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:39:48.133773+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd77d3b98bbc071985840bd365ce7b239516fc8b","claim":"Ginkgo Bioworks Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).","evidence_excerpt":"May 7, 2024, Ginkgo Bioworks Holdings, Inc. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Class A common stock was less than $1.00 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s Class A common stock from the NYSE. Pursuant to Section 802.01C, the Company has a period of six months from receipt of the notice to regain compliance with the minimum stock price lis","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/0001628280-24-022896-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"802.01C"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}